These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289 [TBL] [Abstract][Full Text] [Related]
3. p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history. Smida J; Zitzelsberger H; Kellerer AM; Lehmann L; Minkus G; Negele T; Spelsberg F; Hieber L; Demidchik EP; Lengfelder E; Bauchinger M Int J Cancer; 1997 Dec; 73(6):802-7. PubMed ID: 9399655 [TBL] [Abstract][Full Text] [Related]
4. p53 mutations in all stages of thyroid carcinomas. Zou M; Shi Y; Farid NR J Clin Endocrinol Metab; 1993 Oct; 77(4):1054-8. PubMed ID: 8408453 [TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Shahedian B; Shi Y; Zou M; Farid NR Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841 [TBL] [Abstract][Full Text] [Related]
13. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of RAS point mutations in papillary thyroid carcinoma; a novel mutation at codon 31 of K-RAS. Cyniak-Magierska A; Brzeziańska E; Januszkiewicz-Caulier J; Jarzab B; Lewiński A Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):594-9. PubMed ID: 17943694 [TBL] [Abstract][Full Text] [Related]
15. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970 [TBL] [Abstract][Full Text] [Related]
16. N-ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Hara H; Fulton N; Yashiro T; Ito K; DeGroot LJ; Kaplan EL Surgery; 1994 Dec; 116(6):1010-6. PubMed ID: 7985080 [TBL] [Abstract][Full Text] [Related]
17. [Mutations of p53 gene in 41 cases of human brain gliomas]. Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456 [TBL] [Abstract][Full Text] [Related]
18. Anaplastic changes associated with p53 gene mutation in differentiated thyroid carcinoma after insufficient radioactive iodine (131I) therapy. Sera N; Ashizawa K; Ando T; Ide A; Abe Y; Usa T; Tominaga T; Ejima E; Hayashi T; Shimokawa I; Eguchi K Thyroid; 2000 Nov; 10(11):975-9. PubMed ID: 11128725 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120 [TBL] [Abstract][Full Text] [Related]
20. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Nakamura T; Yana I; Kobayashi T; Shin E; Karakawa K; Fujita S; Miya A; Mori T; Nishisho I; Takai S Jpn J Cancer Res; 1992 Dec; 83(12):1293-8. PubMed ID: 1483945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]